Prospect News: News for Antares Pharma, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with A > Issuers starting with A, PP only > All stories on Antares Pharma, Inc. > Stories on Antares Pharma, Inc., PP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Antares Pharma, Inc.

5/6/2015	PP	Antares Pharma prices its $40 million public stock offering at $2.00
5/5/2015	PP	Antares Pharma reports plans to price public offering of common stock
10/3/2012	PP	Antares Pharma prices $50 million public sale of common stock at $4.00
10/2/2012	PP	Antares Pharma intends to price public offering of its common shares
5/18/2011	PP	Antares Pharma greenshoe exercised, company sells $23 million of stock
5/13/2011	PP	Antares Pharma prices $20 million public offering of common stock
9/18/2009	PP	New Issue: Antares to sell $3 million of units in registered direct offering
7/24/2009	PP	New Issue: Antares Pharma to raise $8.5 million in direct offering of equity units
7/24/2009	PP	Market Commentary: CytRx to sell equity; Prolor retires credit line with placement funds; Cyclacel plans offering
7/10/2007	PP	New Issue: Antares raises another $1 million, lifts stock sale to $16.04 million
7/2/2007	PP	Market Commentary: Linn Energy secures $1.5 billion from units; American Home pockets $125 million
6/29/2007	PP	New Issue: Antares Pharma to close $15.04 million stock offering
6/29/2007	PP	Market Commentary: Primus seals $20.58 million direct placement; Ener1 raises $15 million
3/5/2007	PP	Market Commentary: Austindo plans $20 million convertible note offering; Veridigm prices $4.5 million of stock
3/2/2007	PP	New Issue: Antares Pharma receives $10 million credit agreement with warrants
3/2/2007	PP	Market Commentary: Iomai pockets $31.8 million from unit offering; Antares raises $10 million from loan
3/1/2006	PP	Market Commentary: Akorn secures $19.4 million from private placement; Procera closes $6 million stock deal
2/28/2006	PP	Market Commentary: Advanced Life Sciences prepares to close $36 million PIPE; Antares to settle $10.9 million offering
2/28/2006	BTPP	New Issue: Antares Pharma negotiates $10.96 million private placement of shares
7/11/2005	BTPP	Antares Pharma exchanges 1.2 million shares for all outstanding 1,500 convertible preferreds

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.